PO86 | Emicizumab in patients with moderate hemophilia A and severe bleeding phenotype: single-center real-world experience: A.L. Faccini, M. Biglietto, S. Sorella, E. Crisanti, M. Antonacci, R. Mormile, R. Ciciani, E. Baldacci, C. Santoro, S. Ligia | Hematology, Department of Translational and Precision Medicine Sapienza University of Roma, Italy. Bleeding Thromb Vascul Biol [Internet]. 2025 Aug. 5 [cited 2025 Aug. 6];4(s1). Available from: https://www.btvb.org/btvb/article/view/355